Since this hallmark CLL phenotype marker is up-regulated in CLL cells, it is thought that increased CD5 signaling is another cause of differential CCR7 surface levels between normal and CLL B cells. Here, CCR7 is linked to B-cell chronic lymphocytic leukemia.